Common use of Safe Harbor Statement Clause in Contracts

Safe Harbor Statement. This report contains statements that are not historical facts but rather forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those that address activities, events or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future. All forward-looking statements, including without limitation, management’s examination of historical operating trends and data, as well as estimates of future sales, operating margin, cash flow, effective tax rate or other future operating performance or financial results, are based upon our current expectations, various assumptions and data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Because these forward- looking statements involve risks and uncertainties, the outcome could differ materially from those set out in the forward- looking statements for a variety of reasons, including without limitation, changes in global light vehicle production; fluctuation in vehicle production schedules for which the Company is a supplier, changes in general industry and market conditions, changes in and the successful execution of our capacity alignment, restructuring and cost reduction initiatives discussed herein and the market reaction thereto; loss of business from increased competition; higher raw material, fuel and energy costs; changes in consumer and customer preferences for end products; customer losses; changes in regulatory conditions; customer bankruptcies or divestiture of customer brands; unfavorable fluctuations in currencies or interest rates among the various jurisdictions in which we operate; component shortages; market acceptance of our new products; costs or difficulties related to the integration of any new or acquired businesses and technologies; continued uncertainty in pricing negotiations with customers, our ability to be awarded new business; product liability, warranty and recall claims and other litigation and customer reactions thereto; higher expenses for our pension and other postretirement benefits; work stoppages or other labor issues; possible adverse results of pending or future litigation or infringement claims; negative impacts of antitrust investigations or other governmental investigations and associated litigation (including securities litigation) relating to the conduct of our business; tax assessments by governmental authorities and changes in our effective tax rate; dependence on key personnel; legislative or regulatory changes limiting our business; political conditions; dependence on and relationships with customers and suppliers; and other risks and uncertainties identified under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Reports and Quarterly Reports on Forms 10-K and 10-Q and any amendments thereto. The Company undertakes no obligation to update publicly or revise any forward-looking statements in light of new information or future events. For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update any such statement.

Safe Harbor Statement. This report contains statements that are New risks and uncertainties arise from time to time, and it is not historical facts but rather possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995we may make. Such Factors that could cause actual results to differ materially from these forward-looking statements include those that address activitiesinclude, events or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future. All forward-looking statements, including without limitation, management’s examination the following: general economic conditions; the cyclical nature of historical operating trends automotive sales and data, as well as estimates of future sales, operating margin, cash flow, effective tax rate or other future operating performance or financial results, are based upon our current expectations, various assumptions and data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Because these forward- looking statements involve risks and uncertainties, the outcome could differ materially from those set out in the forward- looking statements for a variety of reasons, including without limitation, changes in global light vehicle production; fluctuation in vehicle production schedules for which the Company is a supplier, changes in general industry and market conditionsconditions or regional growth or decline; further decreases in light vehicle production; impact of COVID-19 on our customers and their production and product launch schedules; impact of COVID-19 on the Company’s financial condition, changes in business operations and liquidity; impact of COVID-19 on our suppliers and availability of components for our products; the development of the software and integrated platform contemplated by the agreement with Qualcomm Technologies and the successful execution availability, timing and commercial success of such software; our capacity alignment, restructuring and cost reduction initiatives discussed herein and ability to achieve the market reaction theretointended benefits from our separation from our former parent; our ability to be awarded new business or loss of business from increased competition; higher than anticipated costs and use of resources related to developing new technologies; higher raw material, fuel energy and energy commodity costs; component shortages; changes in customer and consumer and customer preferences for end products; customer lossesmarket acceptance of our new products; changes in regulatory conditionsdependence on and relationships with customers and suppliers; customer bankruptcies or divestiture of customer brandsour ability to share RD&E costs with our customers; unfavorable fluctuations in currencies or interest rates among the various jurisdictions in which we operate; component shortages; market acceptance of our new products; costs or difficulties related to the integration of any new or acquired businesses and technologies; continued uncertainty in pricing negotiations with customers, our ability to be awarded new businesssuccessful integration of acquisitions and operations of joint ventures; successful implementation of strategic partnerships and collaborations; product liability, warranty and recall claims and investigations and other litigation and customer reactions thereto; higher expenses for our pension and other postretirement post-retirement benefits, including higher funding needs for our pension plans; work stoppages or other labor issues; possible adverse results of pending future litigation, regulatory actions or future litigation investigations or infringement claims; negative impacts of antitrust investigations or other governmental investigations and associated litigation (including securities litigation) relating our ability to the conduct of protect our businessintellectual property rights; tax assessments by governmental authorities and changes in our effective tax rate; dependence on key personnel; legislative or regulatory changes impacting or limiting our business; political conditions; dependence on and relationships with customers and suppliers; and other risks and uncertainties identified under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Reports and Quarterly Reports on Forms 10-K and 10-Q and any amendments thereto. The Company undertakes no obligation to update publicly or revise any forward-looking statements in light of new information or future events. For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, Company's quarterly reports and we assume no obligation to update any such statement.Annual Report on Form 10-K.

Safe Harbor Statement. This report contains statements that are not historical facts but rather press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such Any statements, other than statements of historical fact, including, without limitation, statements regarding Aptevo’s outlook, financial performance or financial condition, our technology and related pipeline, collaboration and partnership opportunities, commercial portfolio, Aptevo’s future growth rates, Aptevo’s ability to timely manufacture its products, and any other statements containing the words “believes,” “expects,” “anticipates,” “intends,” “plans,” “forecasts,” “estimates,” “will” and similar expressions are forward-looking statements. These forward-looking statements include those are based on Aptevo’s current intentions, beliefs and expectations regarding future events. Aptevo cannot guarantee that address activitiesany forward-looking statement will be accurate. Investors should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from Aptevo’s expectations. Investors are, therefore, cautioned not to place undue reliance on any forward-looking statement. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, Aptevo does not undertake to update any forward-looking statement to reflect new information, events or developments circumstances. There are a number of important factors that Autoliv, Inc. or its management believes or anticipates may occur in the future. All could cause our actual results to differ materially from those indicated by such forward-looking statements, including without limitationpossible negative effects on our business operations, management’s examination of historical operating trends and data, as well as estimates of future sales, operating margin, cash flow, effective tax rate or other future operating performance assets or financial results, are based upon results as a result of the separation; a deterioration in our current expectations, various assumptions business or prospects; the ability of our contractors and data available from third parties. Our expectations suppliers to supply product and assumptions are expressed in good faith materials; our ability and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove the ability of our contractors and suppliers to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties maintain compliance with cGMP and other factors which may cause actual future results, performance regulatory obligations; the results of regulatory inspections; adverse developments in our customer-base or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Because these forward- looking statements involve risks markets and uncertainties, the outcome could differ materially from those set out in the forward- looking statements for a variety of reasons, including without limitation, changes in global light vehicle production; fluctuation in vehicle production schedules for which the Company is a supplier, changes in general industry and market conditions, changes in and the successful execution of our capacity alignment, restructuring and cost reduction initiatives discussed herein and the market reaction thereto; loss of business from increased competition; higher raw material, fuel and energy costs; changes in consumer and customer preferences for end products; customer losses; changes in regulatory conditions; customer bankruptcies or divestiture of customer brands; unfavorable fluctuations in currencies or interest rates among the various jurisdictions in which we operate; component shortages; market acceptance of our new products; costs or difficulties related to the integration of any new or acquired businesses and technologies; continued uncertainty in pricing negotiations with customers, our ability to be awarded new businessretain patients; product liabilityadverse developments in the U.S. or global capital markets, warranty and recall claims and other litigation and customer reactions theretocredit markets or economies generally; higher expenses for our pension and other postretirement benefits; work stoppages or other labor issues; possible adverse results of pending or future litigation or infringement claims; negative impacts of antitrust investigations or other governmental investigations and associated litigation (including securities litigation) relating to the conduct of our business; tax assessments by governmental authorities and changes in our effective tax rate; dependence on key personnel; legislative or regulatory changes limiting our business; regulatory, social and political conditions; dependence on and relationships with customers and suppliers; and other . Additional risks and uncertainties identified under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” factors that may affect results are set forth in our filings with the Securities and Exchange Commission, including Aptevo’s most recent Annual Reports and Quarterly Reports Report on Forms Form 10-K K, as filed on March 15, 2017, and our subsequent reports on Form 10-Q and any amendments thereto. current reports on Form 8-K. The Company undertakes no obligation foregoing sets forth many, but not all, of the factors that could cause actual results to update publicly or revise differ from our expectations in any forward-looking statements in light of new information or future eventsstatement. For any forwardAptevo Therapeutics ▇▇▇▇▇▇ Jurchison, Sr. Director, Investor Relations and Corporate Communications ▇▇▇-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward▇▇▇-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update any such statement▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇.▇▇▇

Safe Harbor Statement. This report contains Except for the historical and present factual information contained in this press release, the matters discussed in this press release, including statements that as to the expected benefits of the merger transaction such as efficiencies, market profile, product offerings and financial strength, and the competitive ability and position of the combined bank, and other statements identified by words such as “will,” “expected,” “plans,” “approximately”, and similar expressions are not historical facts but rather forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such These forward-looking statements include are subject to risks and uncertainties that may cause actual results to differ materially from those that address activities, events or developments that Autoliv, Inc. or its management believes or anticipates may occur set forth in the future. All forward-looking statements, including without limitation, management’s examination the following: the ability to obtain regulatory approvals and A▇▇▇▇▇▇▇ shareholder approval of historical operating trends the merger transaction on the proposed terms and data, as well as estimates of future sales, operating margin, cash flow, effective tax rate or other future operating performance or financial results, are based upon our current expectations, various assumptions and data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance schedule; the possibility that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Because these forward- looking statements involve risks and uncertainties, the outcome could differ materially from those set out in the forward- looking statements for a variety of reasons, including without limitation, changes in global light vehicle production; fluctuation in vehicle production schedules for which the Company is a supplier, changes in general industry and market conditions, changes in and the successful execution of our capacity alignment, restructuring and cost reduction initiatives discussed herein and the market reaction thereto; loss of business from increased competition; higher raw material, fuel and energy costs; changes in consumer and customer preferences for end products; customer losses; changes in regulatory conditions; customer bankruptcies or divestiture of customer brands; unfavorable fluctuations in currencies or interest rates among the various jurisdictions in which we operate; component shortages; market acceptance of our new products; costs or difficulties related to the integration of the businesses of A▇▇▇▇▇▇▇ and The Park National Bank will be greater than expected or that the cost savings and any new revenue synergies of the combined banks following the merger transaction may be lower or acquired businesses and technologiestake longer to realize than expected; continued uncertainty in pricing negotiations disruptions from the merger transaction may make it more difficult to maintain relationships with customers, our ability to be awarded new businessemployees or suppliers; product liability, warranty and recall claims and other litigation and customer reactions thereto; higher expenses for our pension and other postretirement benefits; work stoppages or other labor issues; possible adverse results the impact of pending or future litigation or infringement claims; negative impacts of antitrust investigations or other governmental investigations and associated litigation (including securities litigation) relating to the conduct of our business; tax assessments by governmental authorities and changes in our effective tax rate; dependence on key personnel; legislative or regulatory changes limiting our business; political conditions; dependence on and relationships with customers and supplierscompetition; and other risks risk factors relating to our industry as detailed from time to time in the reports of Park filed with the Securities and uncertainties identified under Exchange Commission (the headings “Risk Factors” SEC”). Forward-looking statements speak only as of the date on which they are made, and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Reports and Quarterly Reports on Forms 10-K and 10-Q and any amendments thereto. The Company P▇▇▇ undertakes no obligation to update publicly or revise any forward-looking statements in light of new information statement to reflect events or future eventscircumstances after the date on which the forward-looking statement is made, except as required by applicable law. For any All subsequent written and oral forward-looking statements contained in this attributable to Park or any person acting on P▇▇▇’s behalf are qualified by these cautionary statements. Further information on other document, we claim factors which could affect the protection financial results of Park after the safe harbor for forward-looking statements contained merger transaction are included in Park’s filings with the Private Securities Litigation Reform Act SEC. These documents are available free of 1995, and we assume no obligation to update any such statementcharge through the website maintained by the SEC at h▇▇▇://▇▇▇.▇▇▇.▇▇▇ and/or from Park.

Safe Harbor Statement. This report press release contains statements that are not historical facts but rather forward-looking statements within the meaning for purposes of the Private Securities Litigation Reform Act of 19951995 (the “Act”). Such forward-looking statements include those that address activities, events NeurogesX disclaims any intent or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future. All obligation to update these forward-looking statements, including without limitation, management’s examination of historical operating trends and data, as well as estimates of future sales, operating margin, cash flow, effective tax rate or other future operating performance or financial results, are based upon our current expectations, various assumptions and data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Because these forward- looking statements involve risks and uncertainties, the outcome could differ materially from those set out in the forward- looking statements for a variety of reasons, including without limitation, changes in global light vehicle production; fluctuation in vehicle production schedules for which the Company is a supplier, changes in general industry and market conditions, changes in and the successful execution of our capacity alignment, restructuring and cost reduction initiatives discussed herein and the market reaction thereto; loss of business from increased competition; higher raw material, fuel and energy costs; changes in consumer and customer preferences for end products; customer losses; changes in regulatory conditions; customer bankruptcies or divestiture of customer brands; unfavorable fluctuations in currencies or interest rates among the various jurisdictions in which we operate; component shortages; market acceptance of our new products; costs or difficulties related to the integration of any new or acquired businesses and technologies; continued uncertainty in pricing negotiations with customers, our ability to be awarded new business; product liability, warranty and recall claims and other litigation and customer reactions thereto; higher expenses for our pension and other postretirement benefits; work stoppages or other labor issues; possible adverse results of pending or future litigation or infringement claims; negative impacts of antitrust investigations or other governmental investigations and associated litigation (including securities litigation) relating to the conduct of our business; tax assessments by governmental authorities and changes in our effective tax rate; dependence on key personnel; legislative or regulatory changes limiting our business; political conditions; dependence on and relationships with customers and suppliers; and other risks and uncertainties identified under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Reports and Quarterly Reports on Forms 10-K and 10-Q and any amendments thereto. The Company undertakes no obligation to update publicly or revise any forward-looking statements in light of new information or future events. For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor Safe Harbor for forward-looking statements contained in the Private Securities Litigation Reform Act Act. Examples of 1995such statements include, but are not limited to, expectations with respect to the successful commercial launch and market potential of Qutenza; expectations with respect to the activities of NeurogesX and Astellas under the Distribution, Marketing and License Agreement (the Agreement); the potential receipt of post-execution payments under the Agreement; potential uses of proceeds from the Agreement; expectations regarding additional studies, including a safety study to be carried out by Astellas under the Agreement; the timing of regulatory decisions with respect to the NDA for Qutenza with the FDA, including the PDUFA date for the NDA; plans for entry into a U.S. commercialization partnership for NeurogesX pre-clinical compounds; and plans for clinical development of NGX-1998. Such statements are based on management’s current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to; NeurogesX’ product candidates may have unexpected adverse side effects or inadequate therapeutic efficacy; Astellas may not devote sufficient resources or personnel to the commercialization of Qutenza; adoption of Qutenza by physicians may be longer than anticipated; discussions with governmental or administrative entities may not result in adequate reimbursement or pricing to support commercialization efforts for Qutenza; Astellas may not elect to make option related payments or co-develop NGX-1998; positive results in Qutenza clinical trials may not be sufficient to obtain FDA approval; the FDA may request additional clinical trials or other information prior to granting approval for Qutenza; and other difficulties or delays in the successful commercialization of Qutenza, carrying out activities or obtaining payments under the Agreement and in clinical development of, and we assume no obligation obtaining regulatory approval for, NeurogesX’ product candidates. For further information regarding these and other risks related to update any such statementNeurogesX’ business, investors should consult NeurogesX’ filings with the Securities and Exchange Commission. EXHIBIT D FORM OF SECURITY AGREEMENT This SECURITY AGREEMENT (as amended, supplemented or otherwise modified from time to time in accordance herewith, this “Agreement”) is made and entered into as of April 29, 2010 by and between NeurogesX, Inc., a Delaware corporation (together with its successors and assigns, “NeurogesX”), and ▇▇▇▇▇ Healthcare Royalty Partners, L.P., a Delaware limited partnership (together with its successors and assigns, “CHRP”).

Safe Harbor Statement. This report press release contains statements that are not historical facts but rather forward-looking statements within the meaning of Section 27A of the Private Securities Litigation Reform Act of 19951933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such These statements can be identified by the use of forward-looking statements include those that address activities, events or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future. All forward-looking statementsterminology, including without limitation, management’s examination of historical operating trends "may," "believe," "will," "expect," "anticipate," "estimate," "plan," "intend," and data, as well as estimates of future sales, operating margin, cash flow, effective tax rate "forecast," or other future operating performance or financial results, similar words. Statements contained in this press release are based upon our current expectations, various assumptions and data information presently available from third parties. Our expectations to us and assumptions are expressed in good faith and that we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements reasonable. We are inherently subject not assuming any duty to known and unknown risks, uncertainties and other factors which may cause actual future results, performance update this information should those facts change or achievements should we no longer believe the assumptions to differ materially from the future results, performance or achievements expressed in or implied by be reasonable. Investors are cautioned that all such forward-looking statements. Because these forward- looking statements involve risks and uncertainties, the outcome could differ materially from those set out in the forward- looking statements for a variety of reasons, including without limitation, changes in global light vehicle production; fluctuation in vehicle production schedules statements concerning achieving positive cash flow and profitability, growing our core epilepsy business, appropriately developing our TRD business, and developing VNS as a viable therapy for which the Company is a supplierweight reduction. Our actual results may differ materially. Important factors that may cause actual results to differ include, changes in general industry and market conditions, changes in and the successful execution of our capacity alignment, restructuring and cost reduction initiatives discussed herein and the market reaction thereto; loss of business from increased competition; higher raw material, fuel and energy costs; changes in consumer and customer preferences for end products; customer losses; changes in regulatory conditions; customer bankruptcies or divestiture of customer brands; unfavorable fluctuations in currencies or interest rates among the various jurisdictions in which we operate; component shortages; but are not limited to: continued market acceptance of VNS Therapy and sales of our new productsproduct; costs the development and satisfactory completion of clinical trials and/or market test and/or regulatory approval of VNS Therapy for the treatment of other indications; satisfactory completion of post-market studies required by the U.S. Food and Drug Administration as a condition of approval for the TRD indication; adverse changes in coverage or difficulties related to the integration of any new or acquired businesses reimbursement amounts by third parties; intellectual property protection and technologies; continued uncertainty in pricing negotiations with customers, our ability to be awarded new business; product liability, warranty and recall claims and other litigation and customer reactions thereto; higher expenses for our pension and other postretirement benefits; work stoppages or other labor issues; possible adverse results of pending or future litigation or potential infringement claims; negative impacts maintaining compliance with government regulations and obtaining necessary government approvals for new indications; product liability claims and potential litigation; reliance on single suppliers and manufacturers for certain components; the accuracy of antitrust investigations management's estimates of future expenses and sales; the results of the previously disclosed governmental inquiries; the potential identification of new material weaknesses in our internal controls over financial reporting; risks and costs associated with such governmental inquiries and any litigation relating thereto or other governmental investigations to our stock option grants, procedures, and associated litigation practices (including securities the previously disclosed private litigation) relating to the conduct of our business); tax assessments by governmental authorities and changes in our effective tax rate; dependence on key personnel; legislative or regulatory changes limiting our business; political conditions; dependence on and relationships uncertainties associated with customers and suppliersstockholder litigation; and other risks and uncertainties identified under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” detailed from time to time in our filings with the Securities and Exchange Commission (SEC). For a detailed discussion of these and other cautionary statements, please refer to our most recent filings with the SEC, including our Annual Reports and Quarterly Reports Report on Forms Form 10-K for the fiscal year ended April 27, 2007. This License Agreement (“Agreement”) is entered into as of March 15, 1988 by and 10-Q and any amendments theretobetween CYBERONICS, INC., a Delaware corporation, having a principal place of business at ▇▇▇ ▇. The Company undertakes no obligation to update publicly or revise any forward-looking statements in light of new information or future events. For any forward-looking statements contained in this or any other document▇▇▇▇ ▇▇▇▇▇▇, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995▇▇▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ (“Licensee”), and we assume no obligation to update any such statement▇▇. ▇▇▇▇▇ ▇▇▇▇▇▇, an individual residing at ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, #▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ (“Licensor”).